TrialHaematologica2025

Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial.

Ningjing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.